APA (7th ed.) Citation

Ozaka, M., Ishii, H., Sato, T., Ueno, M., Ikeda, M., Uesugi, K., . . . Furuse, J. (2016). Phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer (MPC). Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 16(4), S30-S31. https://doi.org/10.1016/j.pan.2016.06.120

Chicago Style (17th ed.) Citation

Ozaka, Masato, et al. "Phase II Study of Modified FOLFIRINOX for Chemotherapy-naïve Patients with Metastatic Pancreatic Cancer (MPC)." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.] 16, no. 4 (2016): S30-S31. https://doi.org/10.1016/j.pan.2016.06.120.

MLA (9th ed.) Citation

Ozaka, Masato, et al. "Phase II Study of Modified FOLFIRINOX for Chemotherapy-naïve Patients with Metastatic Pancreatic Cancer (MPC)." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.], vol. 16, no. 4, 2016, pp. S30-S31, https://doi.org/10.1016/j.pan.2016.06.120.